Skip to content
Acta Biologica

Previously: Zeszyty Naukowe Uniwersytetu Szczecińskiego. Acta Biologica

No. 28
Google Scholar
Find in Google Scholar (new tab)

Study of ABO blood grouping and secretor status among habituals – A case control study

DOI: 10.18276/ab.2021.28-04
Cite

The full text is available

ISSN:2450-8330
eISSN:2353-3013
Authors: Srimathi Iyer ORCID
Dept of Oral and Maxillofacial Pathology and Oral Microbiology, SDM College of Dental Sciences and Hospitall, A constituent unit of Shri Dharmasthala Manjunatheswara University

Kaver Hallikeri ORCID
Dept of Oral and Maxillofacial Pathology and Oral Microbiology, SDM College of Dental Sciences and Hospital, A constituent unit of Shri Dharmasthala Manujnatheswara University

Roshni Monteiro ORCID
Dept of Oral and Maxillofacial Pathology and Oral Microbiology, SDM College of Dental Sciences and Hospital, A constituent unit of Shri Dharmasthala Manjunatheswara University

Krishna Burde ORCID
Dept of Oral Medicine and Radiology, SDM College of Dental Sciences and Hospital, A constituent unit of Shri Dharmasthala Manjunatheshwara University
Keywords: blood group antigens habits immunoglobulins oral submucous fibrosis saliva
Issue / book publication date:2021
Page range:8 (33-40)
OAI-PMH:Metadata
CC BY-SA Open Access DOAJ
QR code

Abstract

The study was conducted to analyse ABO blood group and secretor status using saliva among habituals and healthy controls. The relationship between ABO blood group, secretor status of habituals and oral potentially malignant disorders (OPMDs) was assessed. Salivary secretor status was studied in 100 individuals. Clinical and habit history was noted. Group I had 50 age and sex matched healthy controls; group II had 50 individuals having habit history, with or without PMD. With 1ml of unstimulated saliva from each, Wiener agglutination test was performed to know blood group and secretor status. The relationship between ABO blood groups, secretor status, and OPMDs was assessed using Chi-square test and odds ratio. Group I had blood groups A (44%), B (32%), O (14%), AB (10%) and group II had A (32%), B (26%), O (34%), AB (8%). Non-secretor status in group I was 18% and group II, 82%. In Group II, 20% nonsecretors presented with PMD, predominantly oral submucous fibrosis followed by leukoplakia and lichen planus. A definite correlation between salivary secretor status and development of PMD indicates non-secretors possess greater risk of developing oral lesions. Among the habituals, blood groups B and O were at higher risk than A and AB.

PDF

Download PDF
Preview PDF

Open PDF

Bibliography (18)
  1. Amagasa, T., Yamashiro, M., Uzawa, N. (2011). Oral premalignant lesions: from a clinical perspective. Int J Clin Oncol, 16 (1), 5–14. DOI: 10.1007/s10147-010-0157-3.
  2. Auclair, P.L. (1984). Altered H-antigen reactivity as an early indicator of malignant transformation in oral epithelium. J Oral Pathol, 13 (4), 401–411. DOI: 10.1111/j.1600-0714.1984.tb01440.x.
  3. Bakhtiari, S., Far, S.M., Alibakhshi, Z., Shirkhoda, M., Anbari, F. (2019). Salivary Secretor Status of Blood Group Antigens in Patients with Head and Neck Cancer. Open Access Maced J Med Sci, 7 (3), 373– 377. DOI: 10.3889/oamjms.2019.101.
  4. Campi, C., Escovich, L., Valdés, V., García Borrás, S., Racca, L., Racca, A., Cotorruelo, C., Biondi, C. (2007). Secretor status and ABH antigens expression in patients with oral lesions. Med Oral Patol Oral Cir Bucal, 12 (6), E431–434. Retrieved from https://pubmed.ncbi.nlm.nih. gov/?term=Cotorruelo+C&cauthor_id=17909508.
  5. Dabelsteen, E., Pindborg, J.J. (1973). Loss of epithelial blood group substance A in oral carcinomas. Acta Pathol Microbiol Scand A, 81 (4), 435–444. DOI: 10.1111/j.1699-0463.1973.tb00489.x.
  6. D’Adamo, P.J., Kelly, G.S. (2001). Metabolic and immunologic consequences of ABH secretor and Lewis subtype status. Altern Med Rev, 6 (4), 390–405.
  7. Giuliani, M., Troiano, G., Cordaro, M., Corsalini, M., Gioco, G., Lo Muzio, L., Pignatelli, P., Lajolo, C. (2019). Rate of malignant transformation of oral lichen planus: A systematic review. Oral Dis., 25 (3), 693–709. DOI: 10.1111/odi.12885.
  8. Srimathi Iyer, Kaveri Hallikeri, Roshni Monteiro, Krishna Burde 40 Hallikeri, K., Udupa, R., Guttal, K., Naikmasur, V. (2014). Analysis of salivary secretor status in patients with oral submucous fibrosis: a case-control study. J Investig Clin Dent, 6 (4), 261–266. DOI: 10.1111/ jicd.12100.
  9. Jaleel, B.F., Nagarajappa, R. (2012). Relationship between ABO blood groups and oral cancer. Indian J Dent Res, 23 (1), 7–10. DOI: 10.4103/0970-9290.99029.
  10. Kumar, T., Puri, G., Laller, S., Bansal, T., Malik, M. (2014). Association of ABO blood grouping with oral lichen planus. Univ Res J Dent, 4, 93–96.
  11. Lamey, P.J., Darwazeh, A.M., Muirhead, J., Rennie, J.S., Samaranayake, L.P., MacFarlane, T.W. (1991). Chronic hyperplastic candidosis and secretor status. J Oral Pathol Med, 20 (2), 64–67. DOI: 10.1111/ j.1600-0714.1991.tb00891.x.
  12. Metgud, R., Khajuria, N., Mamta, Ramesh, G. (2016). Evaluation of the secretor status of ABO blood group antigens in saliva among southern Rajasthan population using absorption inhibition method. J Clin Diagn Res, 10 (2), ZC01-3. DOI: 10.7860/JCDR/2016/11598.7161.
  13. Moshaverinia, M., Rezazadeh, F., Dalvand, F., Moshaverinia, S., Samani, S. (2014). The relationship between oral lichen planus and blood group antigens. World J Med Sci, 10, 103–105.
  14. Pourazar, A., Joshi, S.R., Sathe, M.S., Advani, S.H., Bhatia, H.M. (1986). Profile of ABH & I antigens in leukaemia. Indian J Med Res, 83, 505–508.
  15. Raaghavan, V.M., Bailoor, D.N., Jhansirani, P. (1986). Incidence of ABO Blood groups in oral cancer in south kanara district. J Indian Dent Assoc, 58, 305–308. PMID: 3458827.
  16. Rai, P., Acharya, S., Hallikeri, K. (2015). Assessment of ABO blood grouping and secretor status in the saliva of the patients with oral potentially malignant disorders. J Oral Maxillofac Pathol, 19 (2), 164–169. DOI: 10.4103/0973-029X.164527.
  17. Tyagi, S.P., Pradhan, S., Agarwal, S.S. (1965). Blood groups in malignant diseases. J Indian Med Assoc, 45 (12), 645–650.
  18. Vidas, I., Delajlija, M., Temmer-Vuksan, B., Stipetić-Mravak, M., Cindrić, N., Maricíć, D. (1999). Examining the secretor status in the saliva of patients with oral pre-cancerous lesions. J Oral Rehabil, 26 (2), 177–182. DOI: 10.1046/j.1365-2842.1999.00314.x.